128
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Pattern of Scleritis in an Egyptian Cohort

, MD, , MD, , MD, , MD, , MD, , MD & , MD show all
Pages 890-896 | Received 14 Aug 2018, Accepted 31 Oct 2018, Published online: 09 Nov 2018

References

  • Akpek EK, Thorne JE, Qazi FA, et al. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111:501–506. doi:10.1016/j.ophtha.2003.06.006.
  • Erkanli L, Akova YA, Guney-Tefekli E, et al. Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey. Cornea. 2010;29:26–33. doi:10.1097/ICO.0b013e3181ac9fad.
  • Lee JE, Oum BS, Choi HY, et al. Methicillin-resistant Staphylococcus aureus sclerokeratitis after pterygium excision. Cornea. 2007;26:744–746. doi:10.1097/ICO.0b013e31804e45ba.
  • O’Donoghue E, Lightman S, Tuft S, et al. Surgically induced necrotising sclerokeratitis (SINS): precipitating factors and response to treatment. Br J Ophthalmol. 1992;76:17–21.
  • Al Barqi M, Behrens A, Alfawaz AM. Clinical features and visual outcomes of scleritis patients presented to tertiary care eye centers in Saudi Arabia. Int J Ophthalmol. 2015;8(6):1215–1219. doi:10.3980/j.issn.2222-3959.2015.06.25.
  • Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60:163–191.
  • Jabs DA, Mudun A, Dunn JP, et al. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130:469–476.
  • Lange C, Feltgen N, Junker B, et al. Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol. 2009;247(1):137–142. doi:10.1007/s00417-008-0926-0.
  • Kwon YH, Kim CS, Zimmerman MB, et al. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. Am J Ophthalmol. 2001;132(1):47–56. doi:10.1016/S0002-9394(01)00912-6.
  • Keino H, Watanabe T, Taki W, et al. Clinical features and visual outcomes of Japanese patients with scleritis. Br J Ophthalmol. 2010;94(11):1459–1463. doi:10.1136/bjo.2009.171744.
  • Sainz de la Maza M, Ns J, Cs F. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389–396.
  • McGavin DD, Williamson J, Forrester JV, et al. Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol. 1976;60(3):192–226.
  • Nakajima N, Hayasaka S. Clinical features of episcleritis and scleritis in some Japanese patients. Ophthalmologica. 1995;209(5):256–259. doi:10.1159/000310626.
  • Bernauer W, Pleisch B, Brunner M. Five-year outcome in immune-mediated scleritis. Graefes Arch Clin Exp Ophthalmol. 2014 Sep;252(9):1477–1481. doi:10.1007/s00417-014-2696-1.
  • Tanaka R, Kaburaki T, Ohtomo K, et al. Clinical characteristics and ocular complications of patients with scleritis in Japanese. Jpn J Ophthalmol. 2018 Jul;62(4):517–524. doi:10.1007/s10384-018-0600-y.
  • Albini TA, Rao NA, Smith RE. The diagnosis and management of anterior scleritis. Int Ophthalmol Clin. 2005;45:191–204. doi:10.1097/01.iio.0000155900.64809.b2.
  • Okhravi N, Odufuwa B, McCluskey P, et al. Scleritis. Surv Ophthalmol. 2005;50:351–363. doi:10.1016/j.survophthal.2005.04.001.
  • Smith JR, Mackensen F, Rosenbaum JT. Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Pract Rheumatol. 2007;3:219–226. doi:10.1038/ncprheum0454.
  • Pavesio CE, Meier FM. Systemic disorders associated with episcleritis and scleritis. Curr Opin Ophthalmol. 2001;12:471–478. doi:10.1097/00055735-200112000-00013.
  • Tuft SJ, Watson PG. Progression of scleral disease. Ophthalmology. 1991;98:467–471. doi:10.1016/S0161-6420(91)32269-3.
  • Sainz de la Maza M, Cs F, Ns J. Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases. Ophthalmology. 1994;101:1281–1288.
  • Ahn SJ, Oh JY, Kim MK, et al. Clinical features, predisposing factors, and treatment outcomes of scleritis in the Korean population. Korean J Ophthalmol. 2010;24(6):331–335. doi:10.3341/kjo.2010.24.6.331.
  • Singh RP, McCluskey P. Scedosporium prolificans sclerokeratitis 10 years after pterygium excision with adjunctive mitomycin C. Clin Experiment Ophthalmol. 2005;33:433–434. doi:10.1111/j.1442-9071.2005.01045.x.
  • Sainz de la Maza M, Ns J, Cs F. An analysis of therapeutic decision for scleritis. Ophthalmology. 1993;100:1372–1376. doi:10.1016/S0161-6420(93)31473-9.
  • Sands DS, Scy C, Gottlieb CC. Methotrexate for the treatment of noninfectious sclertis. Can J Ophthalmol. 2018 Aug;53(4):349–353. doi:10.1016/j.jcjo.2017.11.009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.